Frank A. Oski Memorial Lectureship
The purpose of the annual Frank A. Oski Memorial Lectureship is to honor Dr. Oski's many contributions to the field of pediatric hematology/oncology and ensure a younger generation of pediatric hematology/oncology specialists remains aware of his legacy. The lectureship is awarded to an outstanding clinical or laboratory investigator in pediatric hematology/oncology whose cutting-edge research is of the caliber of the investigations made by Dr. Oski.
Wilbur Lam, MD PhD, a pediatric hematologist/oncologist at Children’s Healthcare of Atlanta, and associate professor of pediatric hematology/oncology at Emory University School of Medicine and biomedical engineering at Emory University/Georgia Institute of Technology, is ASPHO’s 2019 Frank A. Oski Memorial Lectureship recipient.
After completing his undergraduate education in biochemistry and biology at Rice University, Dr. Lam went on to earn his MD at Baylor College of Medicine in 1999, followed by pediatrics residency training at the University of California San Francisco (UCSF) in 2002. He then combined a clinical fellowship at the UCSF Division of Pediatric Hematology/Oncology with a PhD in Bioengineering at UCSF and UC Berkeley, completing both in 2008.
Dr. Lam joined the faculty at Emory University and Georgia Tech in 2011 and since then has built a vibrant laboratory with multiple grants and consistent funding from the most competitive federal funding agencies. He has established himself as a nationally and internationally recognized expert in the application of nanomechanical and microfluidic engineering approaches to studying the biophysics of blood cells, thrombosis, and endothelial cell biology at the cellular level and to developing in vitro “microvasculature-on-a-chip” models of blood diseases. His lab has also published seminal studies discovering and describing how platelets can “sense” and physiologically respond to their physical microenvironments.
Beyond basic science investigations, Dr. Lam and his lab have also sought to apply engineering approaches to developing innovative devices for diagnostic use outside of the usual clinical settings. These include smartphone attachments for remote diagnosis of disease; a color-based, point-of-care diagnostic for measuring hemoglobin levels with a single drop of capillary blood; and a smartphone app that can non-invasively detect and monitor anemia. To further develop the commercial potential of these innovations, he has co-founded two startup companies for which he serves as Chief Medical Officer. He holds eight patents and has four patents pending.
Overall, the Lam Laboratory has developed a “basement-to-bench-to-bedside” approach in which the invention, development, and clinical translation of novel diagnostic and therapeutic micro/nanotechnologies takes place under one scientific roof, with the ultimate goal of improving the lives of children and adolescents with hematologic disorders.
ASPHO is pleased to congratulate Wilbur Lam, MD PhD, on receiving the 2019 Frank A. Oski Memorial Lectureship.
The Frank A. Oski Memorial Lectureship is presented annually to an accomplished clinical or research scientist with an MD, PhD or MD/PhD degree, and while it is not required, ideally they would be a board certified pediatric hematology/oncology specialist. The recipient should be in early or mid-career, be known as an excellent speaker and investigator, and must agree to present a 35-45 minute state-of-the-art lecture describing his/her research at the ASPHO Conference. The recipient need not be a member of ASPHO.
Nomination and Selection Procedure:
Nominations for the Frank A. Oski Memorial Lectureship are solicited from ASPHO members and other leaders in the field, and must include a letter of nomination and a current CV. Nominations will be compiled by the Awards Committee, which will recommend a recipient to the Board of Trustees.
Recognition and Expense Reimbursement:
The Oski recipient will receive complimentary meeting registration, round-trip economy airfare, two nights in the meeting hotel, a $750 honorarium, and an award plaque to be presented prior to the lecture.
Nominations are not currently being accepted for this award.
2018 Julie R. Park, MD
Children’s Hospital & Medical Center
Improvements in Neuroblastoma Therapy: The Fruits of Collaboration
2017 Alexis A. Thompson, MD MPH
Ann & Robert H. Lurie Children's Hospital of Chicago
Advances in Hemoglobinopathies
2016 Joanne Wolfe, MD MPH
Dana-Farber Cancer Institute
Easing Suffering, Enhancing Well-Being: A Program of Research Guided by Pediatric Palliative Care Principles
2015 Stephan A. Grupp, MD PhD
Children's Hosital of Philadelphia
Novel Therapies for Pediatric Leukemia
2014 Scott A. Armstrong, MD PhD
Memorial Sloan-Kettering Cancer Center
New York, NY
MLL-Rearranged Leukemias: Stem Cells, Histone Modifications, and New Therapies
2013 Jorge DiPaola, MD
Children's Hospital Colorado
Platelets and Von Willebrand Factor: An Axis of Good and (Sometimes) Evil
2012 Lillian Sung, MD PhD
Hospital for Sick Children
Toronto, ON, Canada
Decision Making in Pediatric Oncology: Evaluation and Incorporation of Patient and Parent Preferences
2011 Mignon Loh, MD
University of California, San Francisco
San Francisco, CA
Lessons Learned from Studying Children with Hematopoietic Malignancies
2010 Smita Bhatia, MD MPH
City of Hope National Medical Center
Pediatric Cancer Survivorship: Some Well-Traveled Paths—Yet Miles to Go...
2009 Donald Small, MD PhD
FLT3: Biology and Targeting in Leukemia
2008 Todd Golub, MD
Genomic Signatures and Cancer
2007 John Maris, MD
Translating our Evolving Knowledge of Neuroblastoma Biology to Patients with the Disease
2006 David Williams, MD
Cell-Cell Interactions in the Bone Marrow: How Basic Studies in Stem Cell Biology Informed New Therapeutics in Cancer and Gene Therapy
2005 Thomas Look, MD
The Emerging Genetics of T-Cell ALL in Children and Adolescents
2004 Russell Ware, MD PhD
Hydroxyurea for Children with Sickle-cell Disease: Fact, Fiction, and Fantasy
2003 Stuart Orkin, MD
Journey from Thalassemia to Stem Cells
2002 George Dover, MD
Pediatric Hematology/Oncology: A Look into the Future